Effect of the addition of rituximab to salvage chemotherapy prior to autologous stem cell transplant in aggressive CD20+ lymphoma: a cohort comparison from the NCIC Clinical Trials Group Study LY.12*
暂无分享,去创建一个
Bingshu E. Chen | M. Federico | M. Crump | J. Kuruvilla | L. Shepherd | R. Buckstein | D. Szwajcer | R. Meyer | T. Baetz | S. Couban | K. Howson‐Jan | A. Hay | M. Djurfeldt | C. Tom Kouroukis